Related Experiment Video
Updated: Aug 24, 2025

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
Acetaminophen pharmacokinetics in infants and children with congenital heart disease
Jay Holladay1, Peter Winch1,2, James Morse3
1Department of Anesthesiology & Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Insights
Acetaminophen pharmacokinetics in children with congenital heart disease were similar regardless of cyanotic or acyanotic status. This study characterized acetaminophen parameters in pediatric patients following cardiac bypass surgery.
Area of Science:
- Pediatric pharmacology
- Cardiovascular surgery
- Pharmacokinetics
Background:
- Acetaminophen is a standard analgesic for children undergoing major surgery.
- Limited data exist on acetaminophen pharmacokinetics in pediatric patients with congenital heart disease, particularly cyanotic types.
Purpose of the Study:
- To prospectively investigate differences in acetaminophen pharmacokinetics after cardiopulmonary bypass in children with cyanotic versus acyanotic congenital heart disease.
Main Methods:
- A prospective study included children aged 2-6 years undergoing median sternotomy for Fontan palliation (cyanotic) or two ventricle repair (acyanotic).
- A single intravenous dose of acetaminophen (15 mg/kg) was administered post-cardiopulmonary bypass.
- Non-linear mixed effects models were used to describe acetaminophen concentrations, with a two-compartment model with first-order elimination selected.
Main Results:
- Data from 30 children (15 cyanotic, 15 acyanotic) yielded 208 acetaminophen concentrations.
- A two-compartment model best described the data.
- Population pharmacokinetic parameters, including clearance and volume of distribution, were similar between cyanotic and acyanotic groups and comparable to existing literature.
Conclusions:
- Acetaminophen pharmacokinetics in children following cardiac bypass surgery can be described by a two-compartment model.
- No significant differences in acetaminophen clearance or volume parameters were observed between children with cyanotic and acyanotic congenital heart disease.
Background:
Acetaminophen is routinely used for perioperative analgesia in children undergoing major surgical procedures. There are few estimates of acetaminophen pharmacokinetic parameters in children with congenital heart disease, especially those with cyanotic heart disease.
Aims:
The current study prospectively investigated differences in acetaminophen pharmacokinetics following surgery using cardiopulmonary bypass in children with cyanotic and acyanotic congenital heart disease.
Methods:
Children (2-6 years, 9-23 kg) presenting for median sternotomy for Fontan palliation (cyanotic patients) or two ventricle surgical repair (acyanotic patients) were eligible for inclusion. A single intravenous dose of acetaminophen (15 mg/kg) was administered at the start of sternal closure after separation from cardiopulmonary bypass. The time-course of acetaminophen concentrations were described using non-linear mixed effects models. One and two-compartment disposition models with first-order elimination were tested. Pharmacokinetic parameter estimates were scaled using allometry and standardized to a 70 kg person.
Results:
There were 208 acetaminophen concentrations assayed from 30 children, 15 with cyanotic, and 15 with acyanotic heart disease. A 2-compartment model best described acetaminophen PK. Parameter estimates (population parameter variability, PPV%; 95% confidence interval, CI) were clearance CL 15.3 L.h-1.70 kg-1 (22.2%; 13.8-16.7), intercompartment clearance Q 45.4 L.h-1.70 kg-1 (22.4%; 25.2-61.9), central volume of distribution V1 33.5 L.70 kg-1 (23.2%; 25.9-38.8), peripheral volume of distribution V2 32.1 L.70 kg-1 (21.7%; 25.9-38.8). Neither clearance nor volume parameters differed between cyanotic and acyanotic patients.
Conclusions:
Acetaminophen pharmacokinetics were characterized using a 2-compartment model with first-order elimination following cardiac bypass surgery in children. Population pharmacokinetic parameter estimates were similar to other studies in children. No differences were detected between patients with cyanotic and acyanotic heart disease.
Related Concept Videos
Factors Affecting Drug Response: Overview
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...

